Patents by Inventor Sophie Hanscom

Sophie Hanscom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20210069290
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20180185441
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: December 21, 2017
    Publication date: July 5, 2018
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • Immunosuppressive Tat derivative polypeptides
    Patent number: 9878001
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: January 30, 2018
    Assignee: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20140178420
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 26, 2014
    Applicant: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom